← Septic Shock
1G41 Surviving Sepsis Campaign 2021 Class I; bundle, vasopressor and steroid recommendations supported by multiple RCTs

Subset of sepsis with circulatory and cellular/metabolic dysfunction: persisting hypotension requiring vasopressors plus lactate >2 mmol/L despite adequate fluid resuscitation.

⚠ Red flags

  • Lactate >4 after resuscitation — refractory shock
  • LVEF <30% on echo — cardiogenic component
  • Anuric AKI — early RRT
  • DIC — coagulopathy with bleeding/thrombosis

Diagnostic criteria

Clinical

  • Sepsis with persistent hypotension despite adequate fluids
  • Need for vasopressors to maintain MAP ≥65 mmHg

Investigations

  • Lactate >2 mmol/L despite resuscitation

Scoring tools

  • SOFA / qSOFA
  • APACHE II at ICU admission

Investigations

Essential

  • Lactate (serial)
  • Blood cultures ×2 before antibiotics
  • FBC, CRP, procalcitonin, U&E, LFTs, coagulation, ABG
  • Source workup: CXR, urinalysis, focused imaging

Optional

  • Echo / focused cardiac ultrasound for cardiac dysfunction
  • Cortisol if relative adrenal insufficiency suspected

Management

Acute

  • Hour-1 sepsis bundle (see Sepsis guideline)
  • Crystalloid 30 mL/kg within first 3h (reassess responsiveness with PLR/PPV)
  • Noradrenaline first-line vasopressor; titrate to MAP ≥65
  • Add vasopressin 0.03 units/min if noradrenaline >0.25 µg/kg/min
  • Hydrocortisone 200 mg/day IV if refractory shock
  • Dobutamine if myocardial dysfunction documented on echo

Long-term

  • De-escalate antibiotics by 48–72h based on cultures
  • Early rehabilitation when haemodynamically stable

Non-pharmacological

  • Source control (drain, debridement, line removal)
  • DVT and stress ulcer prophylaxis
  • Glycaemic control 7.8–10 mmol/L

Pharmacological

DrugDoseNotes
Noradrenaline 0.05–3 µg/kg/min IV First-line vasopressor.
Vasopressin 0.03 units/min IV (fixed) Add when noradrenaline >0.25 µg/kg/min — catecholamine-sparing.
Hydrocortisone 50 mg IV QDS or 200 mg/day infusion Refractory shock on high-dose vasopressors.
Adrenaline 0.05–1 µg/kg/min IV Third-line vasopressor or if cardiac dysfunction.
Dobutamine 2.5–20 µg/kg/min IV For documented low cardiac output (echo-guided).

Monitoring

  • Continuous arterial line BP, MAP target ≥65
  • Lactate clearance — aim ≥10% per 2h
  • Hourly urine output ≥0.5 mL/kg/h
  • Repeat echo if persistent shock

Referral criteria

  • ICU admission required — all septic shock
  • ECMO centre if profound cardiogenic-septic component

Complications

  • Multi-organ dysfunction syndrome
  • Limb ischaemia from high-dose vasopressors
  • ICU-acquired weakness
  • Post-sepsis cognitive and functional decline

Special populations

Pregnancy
Maintain MAP and uteroplacental perfusion; left lateral tilt; obstetrics involvement early.
Renal impairment
Adjust antibiotic dosing; consider early RRT for refractory acidosis or fluid overload.
Hepatic impairment
Vasopressors may worsen splanchnic perfusion; balance against shock control.
Elderly
Pre-existing frailty informs ICU decisions; lower physiological reserve.
Paediatric
Use weight-based bolus 10–20 mL/kg, reassess; epinephrine may be preferred first-line.
Clinical guidelines summary. Cross-check with the latest source.